11/05/2015 - 21:00 Men treated with androgen-deprivation therapy for advanced prostate cancer appear to be at risk for cognitive decline within 6 months of starting ther... More » Visit websiteField of Interest: OncologyCategories: CME-candidateCNN || NewsCNN || Alzheimers & Cognitive DisordersFPN || NewsFPN || Men's HealthFPN || NeurologyFPN || OncologyIMN || NewsNews Feed: Internal Medicine News - Oncology